Informações:
Falhas:
ID
30047
Descrição
A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1); ODM derived from: https://clinicaltrials.gov/show/NCT01390415
Link
https://clinicaltrials.gov/show/NCT01390415
Palavras-chave
Versões (1)
- 05/05/2018 05/05/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
5 de maio de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hypertension NCT01390415
Eligibility Hypertension NCT01390415
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01390415
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes Mellitus
Item
diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Hypertensive disease | Losartan Dosage
Item
hypertension and has received losartan 50 mg or losartan 100 mg for at least 6 months
boolean
C0020538 (UMLS CUI [1])
C0126174 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0126174 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Microalbuminuria Spot urine procedure
Item
microalbuminuria (defined as microalbuminuria > 30 mg/g and < 300 mg/g by spot urine test)
boolean
C0730345 (UMLS CUI [1,1])
C1272574 (UMLS CUI [1,2])
C1272574 (UMLS CUI [1,2])
Creatinine measurement, serum | Gender
Item
serum creatinine ≤1.5 mg/dl for men and ≤1.4mg/dl for women
boolean
C0201976 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
Urinalysis Leukocytes cells/HPF Quantity
Item
urinalysis with white blood cells (wbc) <5 cells per high power field
boolean
C0042014 (UMLS CUI [1,1])
C0023516 (UMLS CUI [1,2])
C0439358 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C0023516 (UMLS CUI [1,2])
C0439358 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Hemoglobin A1c measurement | Fasting blood glucose measurement | Creatinine measurement, serum | Urine albumin/creatinine ratio measurement | Urinalysis | Status post Initiation Losartan
Item
results of hemoglobin a1c (hba1c), fasting blood glucose, serum creatinine, urine albumin/urine creatinine ratio and urinary analysis tests at baseline and 6 months after initiating the losartan therapy are available
boolean
C0474680 (UMLS CUI [1])
C0428568 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0455271 (UMLS CUI [4])
C0042014 (UMLS CUI [5])
C0231290 (UMLS CUI [6,1])
C1704686 (UMLS CUI [6,2])
C0126174 (UMLS CUI [6,3])
C0428568 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0455271 (UMLS CUI [4])
C0042014 (UMLS CUI [5])
C0231290 (UMLS CUI [6,1])
C1704686 (UMLS CUI [6,2])
C0126174 (UMLS CUI [6,3])
Medical History | Comorbidity | Medical Records
Item
medical history and co-morbidities (if available) listed in medical records
boolean
C0262926 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
C0025102 (UMLS CUI [3])
C0009488 (UMLS CUI [2])
C0025102 (UMLS CUI [3])
Prescription document | Antihypertensive therapy | Losartan Dosage
Item
prescription information of antihypertensive regimen of losartan 50 mg or 100 mg available
boolean
C1521941 (UMLS CUI [1])
C0585941 (UMLS CUI [2])
C0126174 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0585941 (UMLS CUI [2])
C0126174 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
treated with angiotensin-converting enzyme (ace) inhibitors or angiotensin-receptor blockers (arb) before initiated treatment with losartan 50 mg or losartan 100 mg
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0521942 (UMLS CUI [2])
Study Subject Participation Status
Item
enrollment in another clinical trial
boolean
C2348568 (UMLS CUI [1])